Treatment with Activated Protein C (aPC) Is Protective during the Development of Myocardial Fibrosis: An Angiotensin II Infusion Model in Mice

AIMS: Myocardial fibrosis contributes to the development of heart failure. Activated Protein C (aPC) is a circulating anticoagulant with anti-inflammatory and cytoprotective properties. Using a model of myocardial fibrosis second to Angiotensin II (AngII) infusion, we investigated the novel therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sopel, Mryanda J., Rosin, Nicole L., Falkenham, Alec G., Bezuhly, Michael, Esmon, Charles T., Lee, Timothy D. G., Liwski, Robert S., Légaré, Jean-Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446915/
https://www.ncbi.nlm.nih.gov/pubmed/23029168
http://dx.doi.org/10.1371/journal.pone.0045663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446915/
https://www.ncbi.nlm.nih.gov/pubmed/23029168
http://dx.doi.org/10.1371/journal.pone.0045663

Ejemplares similares